 
  
MU: Waiver of Documentation of Consent   
 IRB USE ONLY  
Approval Date: December 12, 2016  
Expi[INVESTIGATOR_5952]: November 20, 2017  WAIVER OF DOCUMENTATION OF CONSENT  
 
INVESTIGATOR ’S NAME: [CONTACT_445708] , PHD    
PROJECT # 2003012  
 
STUDY TITLE: SHARED DECISION MAKING TO IMPROVE PALLIATIVE CARE IN THE NURSING 
HOME 
 
1. I would like to ask you to participate in a study that involves rese arch.  
2. Participation is voluntary and your decision not to participate will not involve any penalty or 
loss of benefits and will in no way affect the nursing home care you receive . 
3. For this study,  your family member will be asked to answer  questions about their experience 
with you in the nursing home.  
4. The purpose of our study is to  investigate ways to improve nursing home care by [CONTACT_445705].  
5. We are asking approximately [ADDRESS_566871] access to the nursing home team 
and your family member . We hope the information learned from this study will benefit other 
nursing home residents and their family.   
9. If you choose t o participate,  Information produced by [CONTACT_445706]’s locked file or secured computer and identified by a code number only. The 
code key connecting your name [CONTACT_445709] a separate, 
secure location. Information contained in your records may not be given to anyone 
unaffiliated with the study in a form that could identify you without your written consent, 
except as required by [CONTACT_2371]. All research materials, including the video recordings and  
transcripts will be maintained for [ADDRESS_566872] of your routine  nursing home .  
 
  
MU: Waiver of Documentation of Consent   
 IRB USE ONLY  
Approval Date: December 12, 2016  
Expi[INVESTIGATOR_5952]: November 20, 2017  10. There is no compensation given t o you for participation in this study , however your family 
will receive $[ADDRESS_566873] any questions regarding your rights as a participant in this research and/or 
concerns about the study, or if you feel under any pressure to enr oll or to continue to 
participate in this study, you may contact [CONTACT_445707] (which is a group of people who review the research studies to 
protect participants’ rights) at (573) [ADDRESS_566874].  
13. A copy of this script will be given to you to keep  